Internal Medicine, Hematology & Oncology · Athens, GA
NPI
1235356247
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3320 Old Jefferson Rd Bldg 700
Athens, GA, 30607
Phone (706) 353-2990
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.4M
120,250 services
Medicare patients, 2024
730
Average age 75
Drug cost, 2024
$4.4M
1,799 prescriptions
Company payments, 2025
$1,795
From 39 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Frederick L Flynt Jr. was code J9263 (injection, oxaliplatin, 0.5 mg), 10,296 times for 11 patients. In total Frederick L Flynt Jr. billed 120,250 services in 202 codes, and Medicare paid $2.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 10,296 | 11 | $0.05 | $522 |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 6,840 | 32 | $6.29 | $43K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 6,676 | 55 | $15.78 | $105K |
| J0897 Injection, denosumab, 1 mg | Office | 5,700 | 39 | $20.58 | $117K |
| J9267 Injection, paclitaxel, 1 mg | Office | 3,352 | 11 | $0.08 | $264 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,198 | 59 | $0.09 | $191 |
| 99214 Office E&M - Established | Office | 1,467 | 539 | $89.75 | $132K |
| 85025 Blood Count | Office | 1,205 | 435 | $7.59 | $9,143 |
| 36415 Venipuncture Blood Collection | Office | 1,198 | 442 | $8.62 | $10K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 1,000 | 28 | $0.07 | $70.65 |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 610 | 14 | $3.03 | $1,848 |
| 96372 Injection Administration | Office | 602 | 148 | $10.22 | $6,154 |
| 96367 Intravenous Infusion, Hydration | Office | 448 | 71 | $20.01 | $8,964 |
| J9190 Injection, fluorouracil, 500 mg | Office | 415 | 13 | $2.07 | $859 |
| 84550 Clinical Chemistry | Office | 414 | 251 | $4.43 | $1,834 |
By year: 2022 $4.6M for 265,146 services; 2023 $3.3M for 187,295 services; 2024 $2.4M for 120,250 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,205 | 435 | $7.59 | $9,143 |
| 36415 Venipuncture Blood Collection | 1,198 | 442 | $8.62 | $10K |
| 84550 Clinical Chemistry | 414 | 251 | $4.43 | $1,834 |
| 83615 Clinical Chemistry | 413 | 250 | $5.92 | $2,445 |
| 80053 Clinical Chemistry | 393 | 246 | $10.35 | $4,068 |
| 88185 Surgical Pathology Examination | 345 | 14 | $16.36 | $5,645 |
| 83883 Clinical Chemistry | 224 | 85 | $13.33 | $2,986 |
| 82784 Immunoassay | 201 | 57 | $9.11 | $1,832 |
| 82728 Clinical Chemistry | 175 | 136 | $13.36 | $2,338 |
| 83540 Clinical Chemistry | 173 | 135 | $6.34 | $1,097 |
Medicare prescription drug claims, 2024
In 2024, the drug Frederick L Flynt Jr. prescribed most often to Medicare patients was Procrit (Epoetin Alfa), with 216 prescriptions and refills. In total Frederick L Flynt Jr. wrote 1,799 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Procrit Epoetin Alfa | 216 | 225 | 22 | $189K |
| Anastrozole Generic | 155 | 349 | 47 | $2,035 |
| Eliquis Apixaban | 72 | 91 | 19 | $53K |
| Letrozole Generic | 69 | 145 | 24 | $1,031 |
| Prednisone Generic | 64 | 64 | 16 | $314 |
| Xarelto Rivaroxaban | 62 | 66 | Under 11 | $36K |
| Mirtazapine Generic | 62 | 94 | 30 | $732 |
| Hydroxyurea Generic | 49 | 73 | Under 11 | $801 |
| Neulasta Onpro Pegfilgrastim | 46 | 46 | Under 11 | $332K |
| Abiraterone Acetate Generic | 37 | 37 | Under 11 | $75K |
| Levothyroxine Sodium Generic | 35 | 50 | Under 11 | $134 |
| Sandostatin Lar Depot Octreotide Acetate,mi-Spheres | 33 | 37 | Under 11 | $252K |
| Lupron Depot Leuprolide Acetate | 32 | 55 | Under 11 | $114K |
| Imatinib Mesylate Generic | 26 | 26 | Under 11 | $2,322 |
| Jakafi Ruxolitinib Phosphate | 26 | 26 | Under 11 | $454K |
Brand drugs: 768 claims; generic drugs: 1,031 claims; opioid claims: 59.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Frederick L Flynt Jr. $1,795 ($1,795 in general payments such as food, travel and fees) from 39 companies. The largest payer was Novartis Pharmaceuticals Corporation with $214.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 9 | $214 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $130 |
| Abbvie Inc. ABBV | 5 | $109 |
| Janssen Biotech, Inc. JNJ | 5 | $98.98 |
| Pfizer Inc. PFE | 5 | $91 |
| Gilead Sciences, Inc. GILD | 3 | $83.18 |
| Array Biopharma Inc PFE | 5 | $75.73 |
| EMD Serono, Inc. MRK.DE | 3 | $68.21 |
| Stemline Therapeutics Inc. | 3 | $62.62 |
| Exelixis Inc. EXEL | 3 | $55.55 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.